Nektar lifted by Merck alliance for bempeg, new trial funding
pharmaphorum
FEBRUARY 18, 2021
The post Nektar lifted by Merck alliance for bempeg, new trial funding appeared first on. The deals with Merck and SFJ are an endorsement of the bempeg programme after initial results from mid-stage studies with the drug generated some lacklustre results in melanoma and triple negative breast cancer (TNBC).
Let's personalize your content